First noninvasive technique to accurately predict mutations in human br... ( DENVER Donald O'Rourke MD Associate...)

First noninvasive technique to accurately predict mutations in human brain tumors

Date:4/20/2009

DENVER Donald O'Rourke, MD, Associate Professor of Neurosurgery at the University of Pennsylvania School of Medicine and colleagues, were able to accurately predict the specific genetic mutation that caused brain cancer in a group of patients studied using magnetic resonance imaging (MRI). The researchers presented their findings this week at the American Association for Cancer Research 100th Annual Meeting 2009.

"The field of cancer research has evolved to the point where the identification of the mutations that cause tumors has changed how we treat patients in a number of cancers," says O'Rourke. "Potentially, we believe we have a method that uses MRI to identify a tumor mutation. Historically tumor mutations have been identified in only one way: take the tissue out and examine it using one of two laboratory tests to see if the mutation is present. In this study we've done this identification noninvasively. To my knowledge this is the first demonstration that an MRI, or any imaging technique, can accurately predict the type of mutation of a human tumor."

A particular MRI technique, called relative cerebral blood volume that measures blood flow to the tumor, very highly correlates with the presence of an important mutation in glioblastoma, a type of brain cancer. The mutation occurs in the epidermal growth factor receptor, EGFR, a well known cancer-related protein that helps tumors form their necessary blood vessels. EGFRvIII, the specific mutation the Penn group studied, is the hallmark of a more aggressive form of glioblastoma.

The research team compared MRI readings to tumor tissue samples from 97 glioblastoma patients. They found that patients with higher relative cerebral blood volume as measured by MRI correlates with the EGFRvIII mutation compared to those who did not have the mutation.

Glioblastoma is a variable disease, and clinicians need help to distinguish one form from another. "All of cancer research is evol
'/>"/>

Contact: Karen Kreeger
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Sitting at the Virtual Poker Table: Results From First Ever Epidemiological Study of Actual Internet Poker Gaming Behavior, in Press
2. IPC The Hospitalist Company, Inc. to Report First Quarter 2009 Financial Results
3. Yashoda Cancer Institute Treats First Patient in India Using RapidArc Radiotherapy Technology
4. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
5. First Annual World Meningitis Day Gaining National Support
6. Lilly Reports Strong First-Quarter 2009 Results
7. First Woman President of the AVMA to Speak at Ross University School of Veterinary Medicine's 2009 Graduation
8. U.S. Venture Investment Lowest in 11 Years, Down 50% to $3.9 Billion in First Quarter
9. ISTA Pharmaceuticals Announces Conference Call and Webcast of First Quarter 2009 Financial Results
10. Pennsylvania Governors Food Safety Council to Hold First Meeting on April 22
11. Caliper Life Sciences First Quarter 2009 Financial Results Conference Call Notice

Post Your Comments:

(Date:5/22/2013)... 2013 Garcinia cambogia select is a dual ... inhibiting the extra fat being stored in the body. For ... intake. This fat burner helps people in this regard by ... overeating. Basically it does this by secreting a hormone serotonin ... them away from emotional overeating. In this way, it keeps ...

(Date:5/22/2013)... (PRWEB) May 22, 2013 On ... the presiding judge for the New York City ... brought by the Long Island Railroad (“LIRR”) against ... resident, who, according to court documents, was diagnosed ... exposure. , According to court documents, the injured ...

(Date:5/22/2013)... these findings in the current online edition of ... study could open up new possibilities of early ... tackle diseases before the patient,s nervous system is ... of genetic diseases of the cerebellum and other ... limited control of their muscles. They also suffer ...

(Date:5/22/2013)... In the long run, encouraging a baby to finish the ... than good. , Though the calories soon burn off, a ... Gibbs and Renata Forste found that clinical obesity at 24 ... "If you are overweight at age two, it puts you ... into middle childhood and adolescence and as an adult," said ...

(Date:5/22/2013)... NY (PRWEB) May 22, 2013 ... now have access to Adapt Courseware’s new ... in an adaptive framework that responds based on ... Courseware , the provider of comprehensive adaptive online ... is continuing to develop introductory level general education ...

Breaking Medicine News(10 mins):Health News:Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply 2 Health News:New York Mesothelioma Lawyers Defeat LIRR’s Motion for Summary Judgment 2 Health News:New York Mesothelioma Lawyers Defeat LIRR’s Motion for Summary Judgment 3 Health News:New York Mesothelioma Lawyers Defeat LIRR’s Motion for Summary Judgment 4 Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 2 Health News:A pan-European study: Signs of motor disorders can appear years before disease manifestation 3 Health News:Overeating learned in infancy, study suggests 2 Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 2 Health News:Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide 3

[0] Garcinia Cambogia Reviews Released Online for Fast Weight Loss Solution with Offer of Extra 3 Month Supply [0] New York Mesothelioma Lawyers Defeat LIRR’s Motion for Summary Judgment [0] A pan-European study: Signs of motor disorders can appear years before disease manifestation [0] Overeating learned in infancy, study suggests [0] Adapt Courseware Releases Introduction to Sociology for Colleges and Universities Nationwide

... Corp. ("Echo" or the "Company") (OTC Bulletin Board: ... meeting of stockholders today,that the polls will remain ... vote on the proposed merger transaction with XLNT,Veterinary ... forth in the,proxy statement/prospectus previously mailed to Echo ...

... The California Nurses,Association/National Nurses Organizing Committee today ... liver transplant one week earlier for,17-year-old Nataline Sarkisyan, ... relented and agreed to the procedure following a ... physicians, including the surgical director of,the Pediatric Liver ...

... EPA, National Contest Urges Young People to Promote ... National Safety,Council has named the winners of its ... the United States Environmental Protection,Agency. First-place winner is ... Arts & Science in Hollywood, Florida; second-place winner ...

... of a songbird may appear effortless, but his elocutions ... youth and maintained throughout adulthood. His tune has virtually ... the motor performance of top athletes and musicians. Yet, ... songbirds and humans. Now, scientists think they know why. ...

... Partnership Co-led by Founder and CEO Dennis Gillings, Bain ... ... Dec. 21 Quintiles,Transnational Corp. today announced the formation of a ... current Chairman and CEO Dennis Gillings, CBE, and the management team.,Gillings ...

... MASI ), the inventor of Pulse CO-Oximetry and ... it is scheduled to,present at the 26th Annual JPMorgan ... CA on Monday, January 7, 2008 at 8:30 a.m. ... de Raad, Executive Vice,President and CFO, will be presenting., ...

Cached Medicine News:Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 2 Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 3 Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 4 Health News:Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 5 Health News:RN's Statement on Death of Nataline Sarkisyan: 'CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago' 2 Health News:National Safety Council Names Winners of Radon Poster Contest 2 Health News:Songbirds offer clues to highly practiced motor skills in humans 2 Health News:Songbirds offer clues to highly practiced motor skills in humans 3 Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 2 Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 3 Health News:Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i 4 Health News:Masimo to Present at 26th Annual JPMorgan Healthcare Conference 2

Echo Healthcare Extends Stockholder Vote on Proposed Merger With XLNT Veterinary Care to December 28, 2007 RN's Statement on Death of Nataline Sarkisyan: 'CIGNA Should Have Listened to her Doctors and Approved the Transplant a Week Ago'National Safety Council Names Winners of Radon Poster Contest Songbirds offer clues to highly practiced motor skills in humans Quintiles Transnational Forms New Ownership Team with Current Investors Gillings, TPG and Temasek Joined by Bain Capital and 3i Masimo to Present at 26th Annual JPMorgan Healthcare Conference

(Date:5/22/2013)... Mass. and TORONTO , ... ) (OTCBB: GNBT) today announced three presentations demonstrating the ... by its wholly-owned subsidiary, Antigen Express, Inc. ( www.antigenexpress.com ... meeting of the American Society of Clinical Oncology (ASCO) ... from May 31 through June 4, 2013. ...

(Date:5/22/2013)... Grifols, ein globales Unternehmen der Gesundheitsbranche ... , Spanien, präsentierte die Ergebnisse einer Studie, ... PROLASTIN©-C (Alpha1-Proteinasehemmer [human]) den Spiegel des Alpha1-Proteins ... Niveau anhebt, das innerhalb des für gesunde ... eine lebensbedrohliche, genetische Erkrankung, bei der der ...

(Date:5/22/2013)... and TORONTO , May 22, 2013 ... that John Mon , Chief Operating Officer, ... on Thursday, May 30, 2013 in New York ... The Company,s presentation is scheduled to begin at 4:00 ... To access the webcast, go to: http://wsw.com/webcast/marcum/mfs.v/ ...

Breaking Medicine Technology:Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 2 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 3 Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine 4 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 2 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 3 Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt 4 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 2 Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference 3

[0] Generex Announces ASCO Presentations on the Antigen Express Advanced Stage AE37 Cancer Vaccine [0] Studie von Grifols zeigt, dass eine höhere Dosis von PROLASTIN-C den Alpha1-PI-Spiegel in Patienten mit AAT-Mangel in den normalen Bereich anhebt [0] Medifocus, Inc. to Present At The Second Annual Marcum LLP MicroCap Conference

... Trubion,s Proprietary ... Product Candidate, SBI-087 for RA Expands Trubion,s Family of Customized, Differentiated ... Product Candidates, ... has initiated a Phase 1/2,clinical trial of TRU-016, the company,s lead proprietary Small Modular,ImmunoPharmaceutical ...

... Encouraging Response in CF Patients - Results Validate ... March 27 The Cystic Fibrosis Foundation,announced today that ... defect in CF, showed promising results in an ongoing ... mutation of CF. The drug is,being developed by Vertex ...

Cached Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5 Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 2 Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF 3

Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update Cystic Fibrosis Foundation Announces Positive Early Results for Phase 2 Clinical Trial of VX-770 - an Oral Compound to Treat CF

Malaria Pf. Assay Range...

An immunochromatographic test for detection of 4 species of Plasmodium antigen ( P. falciparum , P. vivax , P. malariae , P. ovale ) in whole blood....

192 Test HRP-II Enzyme Immunoassay for the presence of Plasmodium falciparum infection....

Malaria device / strip (3 line, PAN-pLDH, P.f.-HRP2)...

Medicine Products:

Malaria Pf. Assay Range PALUTOP+4 Malaria Antigen CELISA Malaria Device / Strip (3 line, PAN-pLDH, P.f.-HRP2)